Status:
COMPLETED
Community Support Program for Lung Cancer Screening
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Conditions:
Lung Cancer
Behavior
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
The research study aims to create a program for lung cancer screening attendance
Detailed Description
The overall objective of this project is to demonstrate the impact of a community support program (CSP) on improving adherence to LCS follow-up guidelines in an urban environment. The project aims to ...
Eligibility Criteria
Inclusion
- Upcoming or missed follow-up LDCT (low dose CT)
- West Philadelphia resident
- Between 18-89 years' old
Exclusion
- No upcoming LDCT
- Lives outside West Philadelphia
- Outside age range
Key Trial Info
Start Date :
February 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2024
Estimated Enrollment :
242 Patients enrolled
Trial Details
Trial ID
NCT06207435
Start Date
February 10 2023
End Date
August 30 2024
Last Update
September 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104